Maja Đanić, PhD, is an Assistant Professor at the Department of Pharmacology, Toxicology, and Clinical Pharmacology, Faculty of Medicine, University of Novi Sad, Serbia. She also completed a healthcare specialization in Clinical Pharmacy at the Faculty of Medicine, University of Novi Sad. She has led research projects focused on pharmacomicrobiomics and the personalization of immunomodulatory therapy in inflammatory bowel disease, and currently leads a project on the development of an innovative low-dose in situ gelling nasal spray for the treatment of allergic rhinitis in children. She has published more than 50 papers in international scientific journals and has authored a chapter in an international scientific monograph. She serves as an Associate Editor, Review Editor, and Guest Associate Editor for Frontiers in Pharmacology and is a member of the Serbian Pharmacological Society. Her teaching disciplines include pharmacology, clinical pharmacology, clinical pharmacy and toxicology, while her research interests include pharmacomicrobiomics, drug–microbiota interactions, drug transport across biological membranes, bile acids as modulators of drug transport, and innovative pharmaceutical formulations.